US Patent Issued to Genzyme, Baylor College of Medicine on July 22 for "Methods for treating osteogenesis imperfecta" (Texas, Massachusetts Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,725, issued on July 22, was assigned to Genzyme Corp. (Cambridge, Mass.) and Baylor College of Medicine (Houston).

"Methods for treating osteogenesis imperfecta" was invented by Brendan Lee (Houston) and Kuber T. Sampath (Holliston, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating and improving the symptoms of osteogenesis imperfecta (OI) in a subject by administering to the subject a therapeutically effective amount of a binding agent that binds to transforming growth factor beta (TGFBeta)."

The patent was filed on Dec. 9, 2021, under Application No. 17/547,069.

*For further information, inc...